Machine Learning for Predicting Hyperglycemic Cases Induced by PD-1/PD-L1 Inhibitors

OBJECTIVE: Immune checkpoint inhibitors, such as programmed death-1/ligand-1 (PD-1/L1), exhibited autoimmune-like disorders, and hyperglycemia was on the top of grade 3 or higher immune-related adverse events. Machine learning is a model from past data for future data prediction. From post-marketing...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jincheng, Li, Ning, Lin, Weilong, Shi, Liming, Deng, Ming, Tong, Qin, Yang, Wenjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417778/
https://www.ncbi.nlm.nih.gov/pubmed/36032541
http://dx.doi.org/10.1155/2022/6278854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417778/
https://www.ncbi.nlm.nih.gov/pubmed/36032541
http://dx.doi.org/10.1155/2022/6278854

Ejemplares similares